Diabetes treatment has advanced since several diabetes organizations united to recommend a “time in range” target of 70-180 mg/dL for glucose levels derived from continuous glucose monitoring (CGM).

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

The effect of antihypertensive treatment for diabetes patients may depend on the level of their systolic blood pressure (SBP) to begin with, a new meta-analysis suggests. The review of 49 trials ...

(Reuters) - Eli Lilly and Co said on Tuesday its experimental diabetes treatment was shown to be as effective as the drugmaker's Humalog medicine in two late-stage studies. The study also found that ...

Johns Hopkins engineers are developing treatments for Type 1 diabetes that don't rely on daily insulin injections or wearing an insulin pump to manage blood sugar levels. Instead, their new cell-based ...

Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...

One challenge of using cell therapy to treat type 1 diabetes is that this approach requires chronic suppression of the immune system to prevent rejection of donor cells. A Vertex Pharmaceuticals ...

SaveHealth reports on managing type 2 diabetes through medications, lifestyle changes, and support, highlighting various treatment options, side effects, and newer therapies.

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

(HealthDay News) — Therapeutic decisions for diabetes should be individualized, considering factors such as ethnicity and cardiovascular risk, according to an ideas and opinions piece published in the ...